X Linked Myotubular Myopathy clinical trials

Explore recruiting x linked myotubular myopathy clinical trials.

Recruiting x linked myotubular myopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

X Linked Myotubular Myopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ASPIRO: A Phase 1/2/3, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients

Germany, France

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 1/2, Multicenter, Open-label, Dose Escalation and Expansion Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of ASP2957 in Male Participants with Invasive Ventilator-dependent X-linked Myotubular Myopathy

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

X Linked Myotubular Myopathy trials by city

X Linked Myotubular Myopathy in Toronto X Linked Myotubular Myopathy in Vancouver X Linked Myotubular Myopathy in Montreal X Linked Myotubular Myopathy in Calgary X Linked Myotubular Myopathy in Edmonton X Linked Myotubular Myopathy in Ottawa X Linked Myotubular Myopathy in Winnipeg X Linked Myotubular Myopathy in Quebec City X Linked Myotubular Myopathy in Hamilton X Linked Myotubular Myopathy in Kitchener X Linked Myotubular Myopathy in London X Linked Myotubular Myopathy in Halifax X Linked Myotubular Myopathy in New York X Linked Myotubular Myopathy in Los Angeles X Linked Myotubular Myopathy in Chicago X Linked Myotubular Myopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease